Literature DB >> 7943326

Developmentally regulated Gb3 galactosyltransferase and alpha-galactosidase determine Shiga toxin receptors in intestine.

M Mobassaleh1, O Koul, K Mishra, R H McCluer, G T Keusch.   

Abstract

The receptor for Shiga toxin on rabbit intestinal microvillus membranes (MVMs) has been identified as a developmentally regulated glycolipid, globotriaosylceramide [galactose alpha 1-4 galactose beta 1-4 glucose beta 1-1 ceramide (Gb3)]. MVM Gb3 levels increase markedly in the third week of life, concomitant with fluid secretory responses to the toxin. To study mechanisms controlling developmental regulation of MVM Gb3, we measured the specific synthetic Gb3 galactosyltransferase and degradative alpha-galactosidase activities and subcellular distribution of Gb3 at various ages. Quantitative high-performance liquid chromatography demonstrated a similar developmental pattern in both microsomal and MVM Gb3, indicating that late expression of MVM Gb3 is not due to delayed migration of Gb3 from the microsomal to the MVM. The specific Gb3 galactosyltransferase activity increased with age, with a sharp increase seen at 18 days of age, whereas alpha-galactosidase activity followed an inverse pattern. Thus, regulation of both synthetic and degradative pathways for Gb3 appears to explain the observed changes in Gb3 levels with age. The nature of the signals for developmental regulation of Gb3 levels is unknown, as are the physiological consequences of altered MVM glycolipid composition other than mediating response to Shiga toxin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943326     DOI: 10.1152/ajpgi.1994.267.4.G618

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Development of recombinant B subunit of Shiga-like toxin 1 as a probe to detect carbohydrate ligands in immunochemical and flowcytometric application.

Authors:  S Miyashita; Y Matsuura; D Miyamoto; Y Suzuki; Y Imai
Journal:  Glycoconj J       Date:  1999-11       Impact factor: 2.916

2.  Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.

Authors:  Steven D Zumbrun; Leanne Hanson; James F Sinclair; James Freedy; Angela R Melton-Celsa; Jaime Rodriguez-Canales; Jeffrey C Hanson; Alison D O'Brien
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

3.  Alpha 1,4galactosyltransferase activity and Gb3Cer expression in human leukaemia/lymphoma cell lines.

Authors:  C L Stults; R D Larsen; B A Macher
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

4.  Expression of nephrin in acquired forms of nephrotic syndrome in childhood.

Authors:  Sangeeta R Hingorani; Laura S Finn; Jolanta Kowalewska; Ruth A McDonald; Allison A Eddy
Journal:  Pediatr Nephrol       Date:  2004-01-28       Impact factor: 3.714

5.  Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells.

Authors:  M S Jacewicz; D W Acheson; M Mobassaleh; A Donohue-Rolfe; K A Balasubramanian; G T Keusch
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 6.  Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections.

Authors:  J C Paton; A W Paton
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

7.  Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib.

Authors:  Samuel M Stone; Cheleste M Thorpe; Amrita Ahluwalia; Arlin B Rogers; Fumiko Obata; Aimee Vozenilek; Glynis L Kolling; Anne V Kane; Bruce E Magun; Dakshina M Jandhyala
Journal:  Front Cell Infect Microbiol       Date:  2012-11-08       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.